Pressure BioSciences, Inc. Share Price Nasdaq
Equities
US74112E1091
Medical Equipment, Supplies & Distribution
End-of-day quote
Other stock markets
|
||
- USD | - |
Sales 2021 | 20.02L 17Cr | Sales 2022 | 17.29L 14Cr | Capitalization | 1.59Cr 132.6Cr |
---|---|---|---|---|---|
Net income 2021 | -2Cr -166.93Cr | Net income 2022 | -1.6Cr -133.54Cr | EV / Sales 2021 | 16.4 x |
Net Debt 2021 | 1.45Cr 121.1Cr | Net Debt 2022 | 2.05Cr 171.31Cr | EV / Sales 2022 | 21.1 x |
P/E ratio 2021 |
-0.68
x | P/E ratio 2022 |
-0.81
x | Employees | - |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 98.82% |
Latest transcript on Pressure BioSciences, Inc.
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 73 | 01/78/01 | |
Edmund Ting
CTO | Chief Tech/Sci/R&D Officer | 70 | 24/06/24 |
Chief Tech/Sci/R&D Officer | 59 | 03/06/03 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 73 | 01/78/01 | |
Vito Mangiardi
BRD | Director/Board Member | 75 | 03/12/03 |
Michael Urdea
BRD | Director/Board Member | 71 | 08/13/08 |
1st Jan change | Capi. | |
---|---|---|
-4.84% | 18TCr | |
+0.56% | 11TCr | |
-3.35% | 6.81TCr | |
+2.39% | 5.05TCr | |
+9.36% | 4.48TCr | |
+2.84% | 4.07TCr | |
+24.51% | 3.23TCr | |
+3.43% | 2.65TCr | |
+15.25% | 2.5TCr |